News
Adicet Bio ACET, a clinical-stage company, develops “off-the-shelf” gamma delta T cell therapies with novel mechanisms of action for patients with cancer and autoimmune diseases. The company ...
LONDON, UK, Nov. 27, 2023 (GLOBE NEWSWIRE) -- Acet.Finance, a prominent staking platform, has unveiled an exciting token airdrop program aimed at rewarding its early stakers. This initiative is a ...
Hosted on MSN1mon
Adicet Bio (ACET) Upgraded to Buy: Here's What You Should Know - MSNAdicet Bio, Inc. (ACET) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates ...
Hosted on MSN4mon
ACT (ACET) and SBH Partner to Transform UAE's Digital Economy - MSNACT (ACET), a world-class digital asset powered by blockchain technology, has signed a landmark Memorandum of Understanding (MOU) with Saif Belhasa Holding (SBH), one of the most influential ...
Adicet Bio Stock Performance. Shares of NASDAQ:ACET opened at $0.78 on Friday. The stock has a market capitalization of $64.71 million, a price-to-earnings ratio of -0.46 and a beta of 1.97.
Adicet Bio ACET, a clinical-stage company, develops “off-the-shelf” gamma delta T cell therapies with novel mechanisms of action for patients with cancer and autoimmune diseases. The company ...
Adicet Bio, Inc. (ACET) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates ...
ACT (ACET), a world-class digital asset powered by blockchain technology, has signed a landmark Memorandum of Understanding (MOU) with Saif Belhasa Holding (SBH), one of the most influential ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results